Abstract
The investigation is an evaluation of intermediate and long-term side effects in patients after high-dose radioiodine treatment due to differentiated thyroid carcinoma. The results demonstrate that severe long-term non-stochastic side effects are rare after high-dose radioiodine treatment of differentiated thyroid carcinoma. Moderate side effects are more common than mentioned in literature. Mostly they are the result of radiation damage to the salivary glands.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Brown AP, Greening WP, McCready VR, Shaw HJ, Harmer CL. Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. Br J Radiol 1984; 57:323–327.
Edmonds CJ, Smith T. The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 1986; 59:45–51.
Van Nostrand D, Neutze J, Atkins F. Side effects of “rational dose” iodine-131 therapy for metastatic well-differentiated thyroid carcinoma. J Nucl Med 1986; 27:1519–1527.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Basel AG
About this paper
Cite this paper
Alexander, C., Sax, B., Bader, J.B., Hellwig, D., Finke, C., Kirsch, CM. (1999). Long-Term Side Effects after High Dose Radioiodine Therapy in Thyroid Carcinoma Patients. In: Bergmann, H., Köhn, H., Sinzinger, H. (eds) Radioactive Isotopes in Clinical Medicine and Research XXIII. Advances in Pharmacological Sciences. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8782-3_59
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8782-3_59
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9772-3
Online ISBN: 978-3-0348-8782-3
eBook Packages: Springer Book Archive